Article

Outcomes in patients with DNA-damage repair related pancreatic cancer

2019-06-03

Abstract excerpt

<title>Abstract</title> <p>Background: Patients with DNA-damage response genes (DDR)-related pancreas cancer (BRCA1/2 or other DNA-damage related genes) may have improved outcomes secondary to increased sensitivity to DNA-damaging drugs (platinum chemotherapy/ poly ADP ribose polymerase (PARP)-inhibitors). However, data is scarce pertaining to outcomes in this subset of patients. Our objective was to retrospectiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 87572446-4976-5a47-a2e8-0cb46b9d9929
DOI: 10.21203/rs.2.10012/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Outcomes in patients with DNA-damage repair related pancreatic cancerDOI 10.21203/rs.2.10012/v1Read

BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future ProspectsSemantic proximity Read

An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known <i>BRCA</i> Mutation: Clinical Descriptors, Treatment Implications, and Future DirectionsSemantic proximity Read

BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment ParadigmsSemantic proximity Read

Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline BRCA or PALB2 MutationsSemantic proximity Read

Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor ProgramSemantic proximity Read

BRCA mutations in pancreatic cancer and progress in their targeting.Semantic proximity Read

Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer.Semantic proximity Read

Germline mutations in pancreatic cancer and potential new therapeutic optionsSemantic proximity Read

Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA VariantsSemantic proximity Read

Pancreas cancer and BRCA : A critical subset of patients with improving therapeutic outcomesSemantic proximity Read

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.Semantic proximity Read

Targeting DNA Damage Repair Mechanisms in Pancreas CancerSemantic proximity Read